Beloranib
Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers
Zafgen · Phase 1 · Completed · Enrollment 31
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| ZGN-433 | Obesity or overweight | n/r | 6 | n/r | n/r |
| Normal Saline | Obesity or overweight | n/r | 6 | n/r | n/r |